×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Dr. Michel Fabbro

18:30
Mot d'accueil
Dr. Michel Fabbro
18:35
Comment les modifications de la prise en charge chirurgicale ont-elles eu un impact sur la chronicisation du cancer de l’ovaire ?
Pr. Pierre-Emmanuel Colombo
18:55
Qualité de vie et soin du support : les inhibiteurs de PARP changent-ils la qualité de vie des patientes ?
Dr. Frédéric Fiteni
19:15
Table ronde d’experts
Pr. Pierre-Emmanuel Colombo, Dr. Michel Fabbro, Dr. Frédéric Fiteni & Dr. Laurence Gladieff
 
Prise en charge d’une patiente présentant un cancer de l’ovaire en rechute – Présentation cas clinique
Dr. Laurence Gladieff
19:45 Q&A
19:55 Qu’avons-nous appris ?
Dr. Michel Fabbro

 

Shooting date : 2021-06-28
Last update : 2021-07-28

Suggestions

Monday, May 10th 2021 from 06pm to 07:30pm (GMT+2)
Honolulu : Monday, May 10th 2021 from 06am to 07:30am (GMT-10)
San Francisco : Monday, May 10th 2021 from 09am to 10:30am (GMT-7)
New York : Monday, May 10th 2021 from 12pm to 01:30pm (GMT-4)
Buenos Aires : Monday, May 10th 2021 from 01pm to 02:30pm (GMT-3)
Reykjavik : Monday, May 10th 2021 from 04pm to 05:30pm (GMT)
London / Dublin : Monday, May 10th 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Monday, May 10th 2021 from 06pm to 07:30pm (GMT+2)
Istanbul : Monday, May 10th 2021 from 07pm to 08:30pm (GMT+3)
Moscou / Dubaï : Monday, May 10th 2021 from 08pm to 09:30pm (GMT+4)
Bangkok : Monday, May 10th 2021 from 11pm to 12:30am (GMT+7)
Shanghai : Tuesday, May 11th 2021 from 12am to 01:30am (GMT+8)
Tokyo : Tuesday, May 11th 2021 from 01am to 02:30am (GMT+9)
Sydney : Tuesday, May 11th 2021 from 03am to 04:30am (GMT+11)
Wellington : Tuesday, May 11th 2021 from 05am to 06:30am (GMT+13)

Tumeurs rares de l’ovaire

à destination des patientes et des professionnels de santé

Share
Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
Honolulu : Monday, October 4th 2021 from 06am to 07:30am (GMT-10)
San Francisco : Monday, October 4th 2021 from 09am to 10:30am (GMT-7)
New York : Monday, October 4th 2021 from 12pm to 01:30pm (GMT-4)
Buenos Aires : Monday, October 4th 2021 from 01pm to 02:30pm (GMT-3)
Reykjavik : Monday, October 4th 2021 from 04pm to 05:30pm (GMT)
London / Dublin : Monday, October 4th 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
Istanbul : Monday, October 4th 2021 from 07pm to 08:30pm (GMT+3)
Moscou / Dubaï : Monday, October 4th 2021 from 08pm to 09:30pm (GMT+4)
Bangkok : Monday, October 4th 2021 from 11pm to 12:30am (GMT+7)
Shanghai : Tuesday, October 5th 2021 from 12am to 01:30am (GMT+8)
Tokyo : Tuesday, October 5th 2021 from 01am to 02:30am (GMT+9)
Sydney : Tuesday, October 5th 2021 from 03am to 04:30am (GMT+11)
Wellington : Tuesday, October 5th 2021 from 05am to 06:30am (GMT+13)

Cancer de l'ovaire : observance long terme sous inhibiteurs de PARP

Episode 1

Share
Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, November 15th 2022 from 06am to 07:30am (GMT-10)
San Francisco : Tuesday, November 15th 2022 from 08am to 09:30am (GMT-8)
New York : Tuesday, November 15th 2022 from 11am to 12:30pm (GMT-5)
Buenos Aires : Tuesday, November 15th 2022 from 01pm to 02:30pm (GMT-3)
London / Dublin : Tuesday, November 15th 2022 from 04pm to 05:30pm (GMT)
Paris / Berlin : Tuesday, November 15th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Tuesday, November 15th 2022 from 08pm to 09:30pm (GMT+4)
Bangkok : Tuesday, November 15th 2022 from 11pm to 12:30am (GMT+7)
Shanghai : Wednesday, November 16th 2022 from 12am to 01:30am (GMT+8)
Tokyo : Wednesday, November 16th 2022 from 01am to 02:30am (GMT+9)
Sydney : Wednesday, November 16th 2022 from 02am to 03:30am (GMT+10)
Wellington : Wednesday, November 16th 2022 from 04am to 05:30am (GMT+12)

Spécificités des soins de support dans le cancer de l'ovaire

Share
Wednesday, March 20th 2024 from 07pm to 08pm (GMT+2)
Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT-10)
San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT-8)
New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT-5)
Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT-3)
London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT)
Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+2)
Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+4)
Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+7)
Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+8)
Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+9)
Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+10)
Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+12)

Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

éclairages du congrès de la SGO

Share
Scroll Up